Jennifer J. Rhodes
General Counsel bei ACADIA PHARMACEUTICALS INC.
Profil
Jennifer J.
Rhodes is currently the Director at Legal Aid At Work and the Secretary, Chief Legal Officer & Executive VP at ACADIA Pharmaceuticals, Inc. She previously worked as an Assistant General Counsel at Pfizer Inc. from 2006 to 2012, a Senior Associate at Weil, Gotshal & Manges LLP from 2000 to 2006, and as the Chief Compliance Officer at Medivation LLC (California) in 2015.
From 2016 to 2020, she was the Secretary, Chief Compliance & Business Officer at Adamas Pharmaceuticals LLC.
She also held a position as the Secretary, Chief Compliance Office & Senior VP at Angion Biomedica Corp.
Ms. Rhodes received her graduate degree from Wake Forest University School of Law and her undergraduate degree from H.
Sophie Newcomb Memorial College.
Aktive Positionen von Jennifer J. Rhodes
| Unternehmen | Position | Beginn |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | General Counsel | 30.01.2024 |
| Legal Aid At Work | Director/Board Member | 01.02.2019 |
Ehemalige bekannte Positionen von Jennifer J. Rhodes
| Unternehmen | Position | Ende |
|---|---|---|
| MEDIVATION INC | Compliance Officer | 01.09.2015 |
| PFIZER, INC. | Corporate Officer/Principal | 01.06.2012 |
Weil, Gotshal & Manges LLP
 Weil, Gotshal & Manges LLP Miscellaneous Commercial ServicesCommercial Services Weil, Gotshal & Manges provides its clients with legal services. The firm offers services to areas including consumer, financial, government and non-profit, health care, industrial, and technology. The company was founded by Claude Serra in 1931 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.04.2006 |
| ANGN BIOM | Compliance Officer | - |
| ADAMAS PHARMACEUTICALS, INC. | Compliance Officer | 01.01.2020 |
Ausbildung von Jennifer J. Rhodes
| Wake Forest University School of Law | Graduate Degree |
| H. Sophie Newcomb Memorial College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Weil, Gotshal & Manges LLP
Weil, Gotshal & Manges LLP Miscellaneous Commercial ServicesCommercial Services Weil, Gotshal & Manges provides its clients with legal services. The firm offers services to areas including consumer, financial, government and non-profit, health care, industrial, and technology. The company was founded by Claude Serra in 1931 and is headquartered in New York, NY. | Commercial Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
| Legal Aid At Work |
